Back

C-ToMExO: Learning Cancer Progression Dynamics from Clonal Composition of Tumors

Mohaghegh Neyshabouri, M.; Dimitrakopoulou, S.; Lagergren, J.

2022-12-23 bioinformatics
10.1101/2022.12.23.521788 bioRxiv
Show abstract

Cancer is an evolutionary process involving the accumulation of somatic mutations in the genome. The tumors evolution is known to be highly influenced by specific somatic mutations in so-called cancer driver genes. Cancer progression models are computational tools used to infer the interactions among cancer driver genes by analyzing the pattern of absence/presence of mutations in different tumors of a cohort. In an abundance of subclonal mutations, discarding the heterogeneity of tumors and investigating the interrelations among the driver genes solely based on tumor-level data can result in misleading interpretations. In this paper, we introduce a computational approach to infer cancer progression models from the clone-level data gathered from a cohort of tumors. Our method leverages the rich clone-level data to identify the patterns of interactions among cancer driver genes and produce significantly more robust and reliable cancer progression models. Using a novel efficient Markov Chain Monte Carlo inference algorithm, our method provides outstanding scalability to the rapidly increasing size of available datasets. Using an extensive set of synthetic data experiments, we demonstrate the performance of our inference method in recovering the generative progression models. Finally, we present our analysis of two sub-types of lung cancer using biological multi-regional bulk data.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.